TKI       mutation        IC50    DDG_exp DDG_prime       DDG_fep1        dDDG_fep1       DDG_fep2        dDDG_fep2       DDG_fep3        dDDG_fep3
axitinib	M244V	690	-0.11	-0.122	0.05	0.41	-0.2	0.41	0.08	0.41
axitinib	L248R	1393	0.31	0.932	2.65	0.44	1.79	0.43	2.27	0.44
axitinib	L248V	1399	0.32	6.226	-0.73	0.42	-0.51	0.42	-0.55	0.41
axitinib	G250E	1295	0.27	0.423	-0.26	0.41	0	0.41	-0.4	0.41
axitinib	Q252H	1155	0.20	1.653	-0.14	0.42	0.41	0.42	0	0.43
axitinib	Y253F	1275	0.26	1.164	1.27	0.43	1.35	0.42	0.46	0.45
axitinib	Y253H	867	0.03	4.488	1.09	0.46	1.53	0.45	1.28	0.48
axitinib	E255K	1282	0.26	0.09	0.71	0.43	1.09	0.43	0.31	0.44
axitinib	E255V	1350	0.30	-0.275	0.78	0.42	0.84	0.42	0.04	0.42
axitinib	D276G	1105	0.18	-0.003	-0.18	0.42	0.01	0.43	0.18	0.42
axitinib	E279K	778	-0.03	-0.145	-0.2	0.43	-0.43	0.42	-0.24	0.43
axitinib	E292L	863	0.03	-0.198	-0.44	0.42	-0.04	0.42	0.65	0.42
axitinib	V299L	188	-0.88	-5.388	-1.66	0.41	-1.68	0.42	-1.48	0.42
axitinib	F311L									
axitinib	T315A	389	-0.45	1.005	0.99	0.43	0.19	0.43	0.52	0.48
axitinib	T315I	98	-1.27	-2.758	-0.23	0.44	-0.38	0.43	-0.52	0.47
axitinib	T315V	45	-1.73	-1.142	-1.99	0.41	-1.54	0.44	-1.8	0.43
axitinib	F317C 									
axitinib	F317I 									
axitinib	F317L	1220	0.23	1.874	0.18	0.41	-0.3	0.41	-0.23	0.41
axitinib	F317R	1286	0.27	-2.427	1.62	0.46	2.4	0.46	2.17	0.45
axitinib	F317V	1320	0.28	2.819	0.65	0.41	0.45	0.42	0.53	0.41
axitinib	M343T	1175	0.21	-0.003	-0.24	0.43	0.02	0.49	0.11	0.49
axitinib	M351T	553	-0.24	-0.011	-0.22	0.41	-0.5	0.41	0.01	0.41
axitinib	E355A 									
axitinib	E355G									
axitinib	F359C 									
axitinib	F359I	975	0.10	-0.037	1.6	0.41	1.06	0.41	0.65	0.41
axitinib	F359V	933	0.07	-0.029	1.2	0.42	0.68	0.43	0.67	0.42
axitinib	V379I									
axitinib	L384M	916	0.06	-0.042	0.01	0.41	0.02	0.41	-0.39	0.41
axitinib	L387M									
axitinib	H396R	1247	0.25	-0.019	0.14	0.42	0.5	0.43	-0.2	0.42
axitinib	F486S	897	0.05	-0.087	0.28	0.47	-0.7	0.49	-0.28	0.46
axitinib	E459K 									
bosutinib	M244V	147	0.43	0.019	-0.28	0.41	-0.11	0.41	-0.08	0.41
bosutinib	L248R	874	1.50	3.667	1	0.43	1.63	0.43	1.33	0.43
bosutinib	L248V	182	0.56	5.767	0.37	0.41	0.72	0.42	0.38	0.42
bosutinib	G250E	85	0.11	-0.297	0.28	0.43	0.63	0.43	-1.07	0.43
bosutinib	Q252H									
bosutinib	Y253F	40	-0.34	-0.033	0.21	0.45	0.02	0.43	0.95	0.43
bosutinib	Y253H									
bosutinib	E255K	181	0.56	0.493	-1.01	0.43	-1.3	0.43	-1.01	0.43
bosutinib	E255V	214	0.66	0.106	-0.47	0.42	-0.51	0.43	-0.91	0.43
bosutinib	D276G									
bosutinib	E279K									
bosutinib	E292L									
bosutinib	V299L	1228	1.70	-0.846	0.97	0.43	0.9	0.42	0.85	0.42
bosutinib	F311L									
bosutinib	T315A	122	0.32	1.004	-1.61	0.41	-1.61	0.41	-1.97	0.41
bosutinib	T315I	4338	2.45	3.746	-2.32	0.43	-2.21	0.42	-1.26	0.42
bosutinib	T315V									
bosutinib	F317C 	165	0.50	4.832	1.04	0.41	1.27	0.41	1.22	0.42
bosutinib	F317I 	232	0.71	1.608	0.16	0.41	0.07	0.42	0.02	0.41
bosutinib	F317L	82	0.09	-0.712	0.05	0.41	0.47	0.41	0.24	0.41
bosutinib	F317R									
bosutinib	F317V	1280	1.72	4.117	1.98	0.42	1.5	0.42	2.25	0.42
bosutinib	M343T									
bosutinib	M351T	97	0.19	0.021	0.36	0.42	0.82	0.41	0.71	0.41
bosutinib	E355A 	74	0.02	0.129	-0.2	0.44	0.13	0.43	0.27	0.43
bosutinib	E355G									
bosutinib	F359C 	70	-0.01	-0.092	3.02	0.42	2.51	0.42	1.97	0.43
bosutinib	F359I	76	0.04	-0.061	0.66	0.41	1.74	0.41	1.43	0.42
bosutinib	F359V	59	-0.11	-0.064	0.98	0.43	1.69	0.41	1.91	0.42
bosutinib	V379I									
bosutinib	L384M									
bosutinib	L387M									
bosutinib	H396R	60	-0.10	-1.068	0.62	0.42	-0.07	0.42	-0.93	0.43
bosutinib	F486S									
bosutinib	E459K 	127	0.35	0.258	-0.69	0.42	0.23	0.42	-0.54	0.42
dasatinib	M244V	2	0.00	-0.099	0.05	0.41	-0.37	0.41	-0.43	0.41
dasatinib	L248R	6	0.65	-2.13	1.4	0.42	1.5	0.43	1.51	0.42
dasatinib	L248V	5	0.55	2.599	0.58	0.42	0.7	0.41	0.79	0.41
dasatinib	G250E	4	0.41	-0.002	-0.54	0.43	-0.31	0.43	0.01	0.44
dasatinib	Q252H									
dasatinib	Y253F	3	0.24	0.002	-0.21	0.43	-0.24	0.43	-0.03	0.44
dasatinib	Y253H									
dasatinib	E255K	9	0.90	-0.08	-0.3	0.43	-0.17	0.44	-1.05	0.43
dasatinib	E255V	11	1.02	-0.084	0.06	0.42	-0.8	0.42	-0.12	0.42
dasatinib	D276G									
dasatinib	E279K									
dasatinib	E292L									
dasatinib	V299L	16	1.24	0.015	0.83	0.41	0.36	0.42	0.77	0.42
dasatinib	F311L									
dasatinib	T315A	59	2.02	5.09	-1.74	0.41	-1.65	0.41	-1.23	0.41
dasatinib	T315I	10000	5.08	-2.685	5.63	0.43	4.69	0.44	5.5	0.43
dasatinib	T315V									
dasatinib	F317C 	45	1.86	4.723	2.63	0.42	2.32	0.42	2.62	0.41
dasatinib	F317I 	40	1.79	2.382	1.94	0.41	2.04	0.41	1.94	0.41
dasatinib	F317L	10	0.96	1.216	1.26	0.41	1.42	0.41	1.08	0.41
dasatinib	F317R									
dasatinib	F317V	104	2.36	4.084	3.12	0.42	2.84	0.42	2.68	0.42
dasatinib	M343T									
dasatinib	M351T	2	0.00	0.042	0.04	0.41	0.14	0.41	0	0.42
dasatinib	E355A 	3	0.24	0.001	-0.24	0.43	-0.87	0.45	-1.25	0.44
dasatinib	E355G									
dasatinib	F359C 	2	0.00	-0.032	1.24	0.42	0.68	0.41	1.38	0.42
dasatinib	F359I	3	0.24	-0.022	-0.5	0.42	-0.33	0.42	-1.14	0.42
dasatinib	F359V	2	0.00	-0.033	-0.87	0.41	0.57	0.42	-0.62	0.41
dasatinib	V379I									
dasatinib	L384M									
dasatinib	L387M									
dasatinib	H396R	2	0.00	2.53	-0.76	0.43	-0.09	0.43	-0.06	0.43
dasatinib	F486S									
dasatinib	E459K 	4	0.41	0.001	-0.68	0.42	-0.17	0.42	-0.07	0.41
erlotinib	M244V									
erlotinib	L248R									
erlotinib	L248V									
erlotinib	G250E									
erlotinib	Q252H	61	-0.13	-0.486	-0.85	0.46	-0.6	0.45	-0.18	0.44
erlotinib	Y253F	76	0.00	-0.029	-0.08	0.44	-0.01	0.43	-0.37	0.43
erlotinib	Y253H									
erlotinib	E255K	63	-0.11	0.653	0.02	0.43	-0.01	0.43	-0.26	0.44
erlotinib	E255V									
erlotinib	D276G									
erlotinib	E279K									
erlotinib	E292L									
erlotinib	V299L									
erlotinib	F311L									
erlotinib	T315A									
erlotinib	T315I	59	-0.15	-4.399	-0.76	0.47	-1.85	0.45	-2.57	0.43
erlotinib	T315V									
erlotinib	F317C 									
erlotinib	F317I 	1100	1.58	3.052	1.04	0.42	1.37	0.42	1.33	0.41
erlotinib	F317L	150	0.40	2.535	0.79	0.42	1.36	0.42	1.1	0.41
erlotinib	F317R									
erlotinib	F317V									
erlotinib	M343T									
erlotinib	M351T	66	-0.08	0.01	0.02	0.41	0.35	0.41	0.08	0.41
erlotinib	E355A 									
erlotinib	E355G									
erlotinib	F359C 									
erlotinib	F359I									
erlotinib	F359V									
erlotinib	V379I									
erlotinib	L384M									
erlotinib	L387M									
erlotinib	H396R									
erlotinib	F486S									
erlotinib	E459K 									
gefitinib	M244V									
gefitinib	L248R									
gefitinib	L248V									
gefitinib	G250E									
gefitinib	Q252H	230	-0.44	-0.938	-0.23	0.43	0.27	0.46	-0.52	0.43
gefitinib	Y253F	360	-0.17	-0.04	0.22	0.44	-0.61	0.45	-0.02	0.46
gefitinib	Y253H									
gefitinib	E255K	400	-0.11	-1.256	0.93	0.43	1.45	0.43	1.32	0.43
gefitinib	E255V									
gefitinib	D276G									
gefitinib	E279K									
gefitinib	E292L									
gefitinib	V299L									
gefitinib	F311L									
gefitinib	T315A									
gefitinib	T315I									
gefitinib	T315V									
gefitinib	F317C 									
gefitinib	F317I 	4700	1.35	1.712	0.69	0.41	0.11	0.41	0.74	0.42
gefitinib	F317L	780	0.29	-0.221	0.38	0.41	1.21	0.41	0.61	0.41
gefitinib	F317R									
gefitinib	F317V									
gefitinib	M343T									
gefitinib	M351T	520	0.05	0.014	-0.24	0.41	0.26	0.41	0.39	0.41
gefitinib	E355A 									
gefitinib	E355G									
gefitinib	F359C 									
gefitinib	F359I									
gefitinib	F359V									
gefitinib	V379I									
gefitinib	L384M									
gefitinib	L387M									
gefitinib	H396R									
gefitinib	F486S									
gefitinib	E459K 									
imatinib	M244V	287	0.21	-0.083	0.15	0.41	0.43	0.41	0.17	0.41
imatinib	L248R	10000	2.33	1.922	1.92	0.43	2.52	0.44	2.34	0.43
imatinib	L248V	586	0.64	1.891	-1.04	0.41	-1.02	0.42	-1.2	0.41
imatinib	G250E	1087	1.01	0.918	0.16	0.41	0.02	0.41	0.12	0.41
imatinib	Q252H									
imatinib	Y253F	4908	1.90	-0.02	0.87	0.43	0.65	0.42	1.34	0.44
imatinib	Y253H									
imatinib	E255K	2487	1.50	0.253	-0.12	0.44	1.95	0.44	-0.55	0.44
imatinib	E255V	8322	2.22	0.241	-0.72	0.42	-0.02	0.42	-0.53	0.43
imatinib	D276G									
imatinib	E279K									
imatinib	E292L									
imatinib	V299L	295	0.23	-1.294	0.66	0.41	0.26	0.42	-0.37	0.42
imatinib	F311L									
imatinib	T315A	476	0.51	5.104	-1.39	0.41	-1.86	0.41	-2.09	0.44
imatinib	T315I	9773	2.32	0.881	4.23	0.43	4.23	0.42	3.14	0.44
imatinib	T315V									
imatinib	F317C 	324	0.28	2.096	0.27	0.42	-0.18	0.41	0.45	0.42
imatinib	F317I 	266	0.17	0.939	0.59	0.41	0.66	0.41	0.48	0.41
imatinib	F317L	675	0.72	0.74	0.58	0.41	0.53	0.41	0.38	0.41
imatinib	F317R									
imatinib	F317V	1023	0.97	1.574	0.71	0.42	0.79	0.42	0.8	0.41
imatinib	M343T									
imatinib	M351T	404	0.42	-0.02	1.72	0.41	1.03	0.42	1.2	0.42
imatinib	E355A 	441	0.47	0.292	0.13	0.43	0.08	0.44	0.14	0.43
imatinib	E355G									
imatinib	F359C 	728	0.77	2.426	0.88	0.42	0.47	0.41	0.33	0.42
imatinib	F359I	324	0.28	1.948	-0.13	0.41	-0.87	0.41	0.08	0.41
imatinib	F359V	346	0.32	2.526	-0.66	0.41	0.02	0.41	-0.27	0.42
imatinib	V379I									
imatinib	L384M									
imatinib	L387M									
imatinib	H396R	395	0.40	2.762	-0.39	0.41	-0.38	0.42	-0.39	0.42
imatinib	F486S									
imatinib	E459K 	612	0.66	0.244	-0.09	0.43	-0.09	0.42	-0.08	0.42
nilotinib	M244V	12	-0.13	-0.113	0.15	0.41	-0.21	0.41	0.21	0.41
nilotinib	L248R	549	2.15	0.476	2.05	0.43	2.12	0.47	1.93	0.43
nilotinib	L248V	26	0.33	3.532	-0.5	0.42	-0.39	0.41	-0.92	0.41
nilotinib	G250E	41	0.60	0.046	0.06	0.41	-0.27	0.41	-0.38	0.41
nilotinib	Q252H									
nilotinib	Y253F	179	1.48	-0.268	1.09	0.43	0.42	0.42	1.16	0.42
nilotinib	Y253H									
nilotinib	E255K	127	1.27	0.411	-2.24	0.48	-1.52	0.46	0.33	0.46
nilotinib	E255V	784	2.36	-0.025	0.31	0.42	-0.25	0.43	-0.55	0.43
nilotinib	D276G									
nilotinib	E279K									
nilotinib	E292L									
nilotinib	V299L	24	0.28	2.941	-0.18	0.41	0.21	0.41	0.15	0.41
nilotinib	F311L									
nilotinib	T315A	50	0.72	3.385	-1.33	0.41	-1.31	0.41	-1.39	0.41
nilotinib	T315I	8091	3.75	4.161	4.29	0.43	5	0.42	4.34	0.43
nilotinib	T315V									
nilotinib	F317C 	16	0.04	0.9	1.34	0.41	0.88	0.41	0.6	0.41
nilotinib	F317I 	25	0.30	-0.184	1.24	0.41	1.17	0.41	0.82	0.41
nilotinib	F317L	21	0.20	1.736	1.03	0.41	1.07	0.41	1.09	0.41
nilotinib	F317R									
nilotinib	F317V	26	0.33	0.767	1.16	0.41	0.68	0.42	1.07	0.42
nilotinib	M343T									
nilotinib	M351T	15	0.00	0.085	-0.06	0.41	-0.09	0.42	-0.46	0.42
nilotinib	E355A 	18	0.11	-0.058	-0.46	0.43	-1.01	0.43	-0.32	0.43
nilotinib	E355G									
nilotinib	F359C 	47	0.68	3.679	1.32	0.41	1.44	0.41	1.52	0.41
nilotinib	F359I	64	0.86	3.7	1.05	0.41	1.13	0.41	0.74	0.41
nilotinib	F359V	41	0.60	3.674	1	0.41	1.08	0.41	1.38	0.42
nilotinib	V379I									
nilotinib	L384M									
nilotinib	L387M									
nilotinib	H396R	23	0.25	2.575	-0.07	0.42	0.21	0.42	0.03	0.42
nilotinib	F486S									
nilotinib	E459K 	38	0.55	-0.004	-0.17	0.42	-0.46	0.42	-0.1	0.42
ponatinib	M244V	3	0.00	-0.127	0.07	0.41	-0.28	0.41	0.12	0.41
ponatinib	L248R	8	0.58	2.476	1.4	0.43	0.96	0.43	1.1	0.44
ponatinib	L248V	4	0.17	2.483	-1.82	0.42	-1.23	0.42	-1.96	0.42
ponatinib	G250E	0.021	0.30	0.174	-0.32	0.43	-0.25	0.43	-0.71	0.46
ponatinib	Q252H									
ponatinib	Y253F	5	0.30	0.053	0.85	0.43	1.32	0.44	0.77	0.43
ponatinib	Y253H									
ponatinib	E255K	6	0.41	1.055	-0.27	0.48	-0.66	0.48	0.03	0.47
ponatinib	E255V	16	1.00	-0.045	1.19	0.43	0.94	0.43	-0.41	0.43
ponatinib	D276G									
ponatinib	E279K									
ponatinib	E292L									
ponatinib	V299L	4	0.17	-0.294	-0.56	0.41	-0.55	0.41	-1.42	0.41
ponatinib	F311L									
ponatinib	T315A	4	0.17	-0.512	-2.9	0.41	-3.15	0.41	-2.92	0.41
ponatinib	T315I	6	0.41	-5.424	0.51	0.42	0.9	0.42	0.91	0.42
ponatinib	T315V									
ponatinib	F317C 	3	0.00	1.451	0.44	0.41	0.98	0.42	0.8	0.41
ponatinib	F317I 	7	0.51	0.617	-0.76	0.41	-1.03	0.41	-1.02	0.41
ponatinib	F317L	4	0.17	0.566	-1.08	0.41	-0.83	0.41	-0.85	0.41
ponatinib	F317R									
ponatinib	F317V	10	0.72	1.142	0.05	0.41	-0.21	0.41	0.24	0.42
ponatinib	M343T									
ponatinib	M351T	4	0.17	-0.116	0.89	0.41	1.66	0.41	0.65	0.41
ponatinib	E355A 	7	0.51	0.009	0.12	0.44	-0.52	0.44	-0.55	0.43
ponatinib	E355G									
ponatinib	F359C 	6	0.41	2.115	0.25	0.42	-0.35	0.43	0.73	0.42
ponatinib	F359I	11	0.77	0.344	-0.66	0.41	-0.38	0.41	0.06	0.41
ponatinib	F359V	4	0.17	0.743	0.11	0.41	-0.28	0.41	0.08	0.42
ponatinib	V379I									
ponatinib	L384M									
ponatinib	L387M									
ponatinib	H396R	4	0.17	-0.043	0.19	0.49	0.1	0.45	-1.41	0.48
ponatinib	F486S									
ponatinib	E459K 	5	0.30	-0.001	-0.51	0.42	-0.78	0.42	-0.63	0.42
